Krystal Biotech, Inc. announced that Andrew Orth, the company?s Chief Commercial Officer, notified the company that he was resigning from his position and his last day with the Company was August 2, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.6 USD | +4.06% | +7.21% | +35.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.12% | 4.79B | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+2.18% | 22.67B | |
-10.09% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- KRYS Stock
- News Krystal Biotech, Inc.
- Krystal Biotech, Inc. Announces Resignation of Andrew Orth as Chief Commercial Officer